GA32.0ICD-11 MMS 2026-01
Ovarian hyperstimulation syndrome
Description
A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms.
Index terms
- Ovarian hyperstimulation syndrome
- Hyperstimulation of ovaries associated with induced ovulation
- OHSS - [Ovarian hyperstimulation syndrome]
Show allHide
- hyperstimulation of ovaries NOS
Inclusions
- Hyperstimulation of ovaries associated with induced ovulation
Exclusions from above levels
01– Certain infectious or parasitic diseases05– Endocrine, nutritional or metabolic diseases18– Complications of pregnancy, childbirth and the puerperium
Show allHide
22– Injury, poisoning or certain other consequences of external causes
Sibling codes
GA32.1– Bleeding after egg retrievalGA32.2– Infection associated with medically assisted reproductionGA32.3– Complications of attempted embryo transfer or medically assisted inseminationGA32.Y– Other specified complications associated with medically assisted reproductionGA32.Z– Complications associated with medically assisted reproduction, unspecified
Foundation entity
Ovarian hyperstimulation syndrome – http://id.who.int/icd/entity/1216664013
Allowed postcoordination axes
Part of: GA32: Complications associated with medically assisted reproduction › 16: Diseases of the genitourinary system